OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Table. 2.

Table. 2.

Results of cost-effectiveness analysis

Testing strategy Cost ($) PF-LYG (y) ICER ($/PF-LYG)
Strategy 1 1,680.0 0.41 3,978.4
Strategy 2 1,711.1 0.41 4,054.1
Strategy 3 1,773.5 0.41 4,205.7
Strategy 4 784.9 0.29 2,547.7
Strategy 5 1,696.9 0.41 4,019.7
No testing (comparator) 42.3 referent

Abbreviations: PF-LYG, progression-free life-year gain; ICER, incremental cost-effectiveness ratio.

© Ann Lab Med